OverviewChartNewsTraderScreen

BVT Put 145 NVO 20.12.2024/  DE000VD7QVR0  /

Frankfurt Zert./VONT
8/9/2024  7:57:06 PM Chg.-0.400 Bid9:59:41 PM Ask9:59:41 PM Underlying Strike price Expiration date Option type
1.590EUR -20.10% -
Bid Size: -		 -
Ask Size: -		 Novo Nordisk 145.00 - 12/20/2024 Put
TeleTrader 8/7 Europe higher premarket amid earnings reports
TeleTrader 7/5 Novo Nordisk slammed over undisclosed payments
GlobeNewswire 7/2 Notified Celebrates Winners of 2024 IR Magazine European Awards
GlobeNewswire 6/28 SNIPR Biome receives funding for the development of CRISPR-medicines to improve Environmental Enteri...
GlobeNewswire 6/27 Arch Biopartners Announces GMP Manufacturing of Cilastatin Drug Product
GlobeNewswire 6/24 Veru Announces Safety and Body Composition Data from Two Late-Breaker Presentations at the American ...
GlobeNewswire 6/18 Novo Nordisk announces presentation of data from key semaglutide clinical trials in diabetes, obesit...
GlobeNewswire 6/18 Arch Biopartners Announces University of Calgary Ethics Approval to Proceed with Phase II Trial for ...
GlobeNewswire 6/17 Veru Reminds Shareholders to Vote in Advance of Tomorrow’s Deadline for 2024 Annual Meeting of Share...
TeleTrader 6/15 Novo Nordisk CEO to voluntarily testify before US committee
GlobeNewswire 6/14 Elevai Labs Forms New Scientific Advisory Board for its Weight Loss Programs
GlobeNewswire 6/13 Aeterna Zentaris Announces Last Patient Last Visit in Pivotal DETECT-Trial for the Diagnosis of Chil...
GlobeNewswire 6/13 Biosplice Announces Collaboration with Novo Nordisk in Diabetes
GlobeNewswire 6/11 Biora Therapeutics Announces Presentation on the BioJet™ Systemic Oral Delivery Platform at the Next...
GlobeNewswire 6/10 RenovoRx Appoints Ryan Witt as Senior Vice President, Head of Corporate Strategy and Partnerships
GlobeNewswire 6/10 Veru to Present at the American Diabetes Association's 84th Scientific Sessions
GlobeNewswire 6/3 Aeterna Zentaris and Ceapro Complete Merger Transaction
GlobeNewswire 6/3 Aeterna Zentaris and Ceapro Complete Merger Transaction
GlobeNewswire 5/31 Zealand Pharma announces positive CHMP opinion for dasiglucagon for treatment of severe hypoglycemia...
GlobeNewswire 5/30 Anaqua Annual User Experience Conference to Feature Keynotes from Microsoft, SAP, USPTO, and More
GlobeNewswire 5/22 Veru to Present at the Jefferies Global Healthcare Conference
GlobeNewswire 5/15 Veru Announces Steven B. Heymsfield M.D. as the Principal Investigator for its Enobosarm Phase 2b Cl...
GlobeNewswire 5/15 Aeterna Zentaris Reports First Quarter 2024 Financial Results
GlobeNewswire 5/14 Veru Announces Mitchell Steiner as Keynote Speaker at Biomed Israel 2024: The 22nd National Life Sci...
GlobeNewswire 5/9 US Neurologists Report Route of Administration as a Critical Factor when Evaluating Future Parkinson...